BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 26833073)

  • 1. Synthesis, Antibacterial Activity, Interaction with Nucleobase and Molecular Docking Studies of 4-Formylbenzoic Acid Based Thiazoles.
    Laczkowski KZ; Biernasiuk A; Baranowska-Laczkowska A; Misiura K; Malm A; Plech T; Paneth A
    Med Chem; 2016; 12(6):553-62. PubMed ID: 26833073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel anti-tubercular and antibacterial based benzosuberone-thiazole moieties: Synthesis, molecular docking analysis, DNA gyrase supercoiling and ATPase activity.
    Omar MA; Masaret GS; Abbas EMH; Abdel-Aziz MM; Harras MF; Farghaly TA
    Bioorg Chem; 2020 Nov; 104():104316. PubMed ID: 33022549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
    Lv PC; Wang KR; Yang Y; Mao WJ; Chen J; Xiong J; Zhu HL
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6750-4. PubMed ID: 19836235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel coumarin-thiazolyl ester derivatives as potential DNA gyrase Inhibitors: Design, synthesis, and antibacterial activity.
    Liu H; Xia DG; Chu ZW; Hu R; Cheng X; Lv XH
    Bioorg Chem; 2020 Jul; 100():103907. PubMed ID: 32413631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
    Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro biological evaluation of novel broad-spectrum isothiazolone inhibitors of bacterial type II topoisomerases.
    Charrier C; Salisbury AM; Savage VJ; Moyo E; Forward H; Ooi N; Cheung J; Metzger R; McGarry D; Walker R; Cooper IR; Ratcliffe AJ; Stokes NR
    J Antimicrob Chemother; 2016 Oct; 71(10):2831-9. PubMed ID: 27353465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV.
    Metwally NH; Abdallah SO; Mohsen MMA
    Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 1,2,4-oxadiazole-chalcone/oxime hybrids as potential antibacterial DNA gyrase inhibitors: Design, synthesis, ADMET prediction and molecular docking study.
    Ibrahim TS; Almalki AJ; Moustafa AH; Allam RM; Abuo-Rahma GEA; El Subbagh HI; Mohamed MFA
    Bioorg Chem; 2021 Jun; 111():104885. PubMed ID: 33838559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and antibacterial activity studies of thiazole derivatives as potent ecKAS III inhibitors.
    Cheng K; Xue JY; Zhu HL
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4235-8. PubMed ID: 23731945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzothiazole Clubbed Imidazolone Derivatives: Synthesis, Molecular Docking, DFT Studies, and Antimicrobial Studies.
    Desai N; Maheta A; Jethawa A; Ahmad I; Patel H; Dave B
    Curr Comput Aided Drug Des; 2023; 19(2):123-136. PubMed ID: 36411562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors.
    Hashem HE; Amr AEE; Nossier ES; Elsayed EA; Azmy EM
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32549386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors.
    Durcik M; Tammela P; Barančoková M; Tomašič T; Ilaš J; Kikelj D; Zidar N
    ChemMedChem; 2018 Jan; 13(2):186-198. PubMed ID: 29206345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial Evaluation and Virtual Screening of New Thiazolyl-Triazole Schiff Bases as Potential DNA-Gyrase Inhibitors.
    Nastasă C; Vodnar DC; Ionuţ I; Stana A; Benedec D; Tamaian R; Oniga O; Tiperciuc B
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of 1-ethyl-3-(thiazol-2-yl)urea derivatives as Escherichia coli DNA gyrase inhibitors.
    Tomašič T; Barančoková M; Zidar N; Ilaš J; Tammela P; Kikelj D
    Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29239018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and In Silico Molecular Docking Studies on Substituted Piperic Acid Derivatives as Inhibitors of Bacterial DNA Gyrase.
    Chopra B; Dhingra AK; Prasad DN; Bhardwaj S; Dubey S
    Curr Comput Aided Drug Des; 2020; 16(3):281-294. PubMed ID: 31288729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, in vitro biological screening and molecular docking studies of novel camphor-based thiazoles.
    Laczkowski KZ; Misiura K; Biernasiuk A; Malm A; Siwek A; Plech T; Ciok-Pater E; Skowron K; Gospodarek E
    Med Chem; 2014; 10(6):600-8. PubMed ID: 25019315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, Evaluation of Antimicrobial Activity and Docking Studies of New Thiazole-based Chalcones.
    Tratrat C; Haroun M; Xenikakis I; Liaras K; Tsolaki E; Eleftheriou P; Petrou A; Aldhubiab B; Attimarad M; Venugopala KN; Harsha S; Elsewedy HS; Geronikaki A; Soković M
    Curr Top Med Chem; 2019; 19(5):356-375. PubMed ID: 30706816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiophene and benzodioxole appended thiazolyl-pyrazoline compounds: Microwave assisted synthesis, antimicrobial and molecular docking studies.
    Shahavar Sulthana S; Arul Antony S; Balachandran C; Syed Shafi S
    Bioorg Med Chem Lett; 2015 Jul; 25(14):2753-7. PubMed ID: 26028159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents.
    Wiles JA; Hashimoto A; Thanassi JA; Cheng J; Incarvito CD; Deshpande M; Pucci MJ; Bradbury BJ
    J Med Chem; 2006 Jan; 49(1):39-42. PubMed ID: 16392790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
    Alagumuthu M; Arumugam S
    Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.